Key Insights

Highlights

Treatment Research

3 treatments under study, led by Maltodextrin

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

100.0%

1 terminated out of 1 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Terminated1

Clinical Trials (1)

Showing 1 of 1 trials
NCT02232373Not ApplicableTerminatedPrimary

Campylobacter Enteritis and PI-BD: Dietary Reduction in Carbohydrates

Showing all 1 trials

Research Network

Common Treatments

  • Maltodextrin1
  • Low Fodmap Dietary Advice1
  • Oligofructose1

Active Sponsors

  • King's College London1
  • Nottingham University Hospitals NHS Trust1
  • University of Nottingham1

Top Investigators

Related Conditions

  • Functional Gastrointestinal Disorders1

Activity Timeline